These analyses revealed that, in lung cancer cells after REV1 deletion, numerous metabolism-related pathways underwent significant enrichment, such as phenylalanine metabolism, selenocompound metabolism, and Gly/Ser/Thr metabolism, suggesting that the function of REV1 might be related to metabolic factors (Fig. 2A). The gene discussed is REV1; the disease is lung carcinoma.